Xemperia
Fribourg · Founded 2023
About Xemperia
At XEMPERIA, we are pioneering a groundbreaking concept for a blood test that effectively detects breast cancer at its earliest stage by harnessing the body’s immune response. Suitable for any women and age this innovative test offers superior performance to mammography and will serve as the first-line option in the breast cancer screening process.
Company Facts
- Founded: 2023
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: Less than $1M
- Total funding: $111.5K
- Last round: Debt Financing (Jun 2024)
- Website: https://xemperia.com
- Phone: [email protected]
Industries & Categories
Health Care, Health Diagnostics
Social Profiles
Canonical: https://fsome.com/organization/xemperia-31732 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.